Stay updated with breaking news from 46433010. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AtonRa Partners lowered its holdings in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Free Report) by 11.0% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 12,344 shares of the company’s stock after selling 1,531 shares during the quarter. AtonRa Partners’ holdings in […]
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) has earned an average rating of “Hold” from the ten analysts that are presently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and five have given a buy recommendation to the company. The […]
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Free Report) was the target of a large growth in short interest in June. As of June 15th, there was short interest totalling 8,690,000 shares, a growth of 33.3% from the May 31st total of 6,520,000 shares. Based on an average trading volume of 1,210,000 shares, the short-interest ratio is […]
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Free Report) was the target of a large growth in short interest in June. As of June 15th, there was short interest totalling 8,690,000 shares, a growth of 33.3% from the May 31st total of 6,520,000 shares. Based on an average daily trading volume, of 1,210,000 shares, the days-to-cover ratio […]
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) shares gapped down prior to trading on Wednesday . The stock had previously closed at $43.33, but opened at $40.49. Ionis Pharmaceuticals shares last traded at $41.18, with a volume of 334,112 shares changing hands. Wall Street Analyst Weigh In A number of research firms have recently commented […]